Alzheimer And Dementia Treatment
-
{
- All
- News
-
What I Tell Families When They Ask: Should We Put My Parent On The New Drug, Lormalzi?
Lormalzi is not a cure. I say this not to take away hope, but because understanding this is what allows families to make decisions rooted in reality rather than desperation.
-
Who Should Take Lormalzi? Alzheimer's Expert Explains Benefits And Risks
Neurologists say Lormalzi (donanemab), India's newly launched Alzheimer's therapy, may help slow cognitive decline in carefully selected patients with early disease. Experts explain who may benefit, who should avoid it, and the risks involved.
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Early Alzheimer's Detection Is Changing How Indian Families Plan Daily Life; Doctor Explains Shift
Forgetting routes and repeating questions may not be normal ageing. Early Alzheimer's detection is helping Indian families prepare emotionally, medically and financially, says neurologist Dr Renjen.
-
Hearing Loss An Early Warning Sign For Alzheimer's, Study Warns: Don't Ignore These Other Red Flags
A growing body of research now points to hearing loss as a compelling early indicator of Alzheimer's disease.
-
Doctor Shares Tips To Slow Down The Progression Of Alzheimer's Disease
Alzheimer's disease is the most common cause of dementia. While there's no cure for dementia, medication and treatments like cognitive behavioural therapy might help manage symptoms.
-
World Alzheimer's Day 2025: Doctor Busts Myths, Explains Why Early Detection Truly Matters
Dr Vinit Banga (Director & HOD, Neurology, Fortis Faridabad) walks us through common myths, what science shows about early diagnosis, and how knowing the truth can change outcomes for patients and families.
-
Other Kinds Of Dementias You May Not Know About
Understanding these other forms of dementia is essential for early detection, proper treatment, and support for both patients and caregivers.
-
Enzyme Link To Memory Loss In Mice Could Lead To Alzheimer's Breakthrough
A new mice study may have found an association between an enzyme and memory loss in elderly people, an advance that can someday pave the way for the treatment of Alzheimer's disease and dementia.
-
World Alzheimer's Day 2023: Here's How Alzheimer's Symptoms Are Different From Age-Related Forgetfulness
World Alzheimer's Day 2023: Read on as we discuss how Alzheimer's symptoms differ from normal forgetfulness.
-
Brain: These 9 Everyday Practices Will Lower Your Risk Of Alzheimer's Disease
Keep reading as we list everyday habits that can reduce your risk of developing Alzheimer's disease.
-
Groundbreaking New Alzheimer's Drug Slows Progression Of The Disease, Finds Study
The medication had a successful clinical trial and is expected to be approved by the Food and Drug Administration this fall.
-
This AI Tool Makes Personalized Alzheimer's Treatment Plans For Dementia Patients
RestoreU is an AI tool developed by a US-based company to assist doctors in developing care plans for patients with Alzheimer's and other kinds of dementia.
-
What Is Frontotemporal Dementia? All About Bruce Willis' Diagnosis
Frontotemporal dementia is a common cause of dementia, is a group of disorders that occur when nerve cells in the frontal and temporal lobes of the brain are lost.
-
New Study Might Lead to New Therapeutic Approach for Treating Alzheimer’s Disease
Researchers have used a new CRISPR technology that enables them to control these microglia cells. This, according to the team, can lead to a new approach to the treatment of Alzheimer's disease. The team geared up to detect the genes that were responsible for specific states of the microglial activity. With this, they could switch the genes on and ...
-
What I Tell Families When They Ask: Should We Put My Parent On The New Drug, Lormalzi?
Lormalzi is not a cure. I say this not to take away hope, but because understanding this is what allows families to make decisions rooted in reality rather than desperation.
-
Who Should Take Lormalzi? Alzheimer's Expert Explains Benefits And Risks
Neurologists say Lormalzi (donanemab), India's newly launched Alzheimer's therapy, may help slow cognitive decline in carefully selected patients with early disease. Experts explain who may benefit, who should avoid it, and the risks involved.
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Early Alzheimer's Detection Is Changing How Indian Families Plan Daily Life; Doctor Explains Shift
Forgetting routes and repeating questions may not be normal ageing. Early Alzheimer's detection is helping Indian families prepare emotionally, medically and financially, says neurologist Dr Renjen.
-
Hearing Loss An Early Warning Sign For Alzheimer's, Study Warns: Don't Ignore These Other Red Flags
A growing body of research now points to hearing loss as a compelling early indicator of Alzheimer's disease.
-
Doctor Shares Tips To Slow Down The Progression Of Alzheimer's Disease
Alzheimer's disease is the most common cause of dementia. While there's no cure for dementia, medication and treatments like cognitive behavioural therapy might help manage symptoms.
-
World Alzheimer's Day 2025: Doctor Busts Myths, Explains Why Early Detection Truly Matters
Dr Vinit Banga (Director & HOD, Neurology, Fortis Faridabad) walks us through common myths, what science shows about early diagnosis, and how knowing the truth can change outcomes for patients and families.
-
Other Kinds Of Dementias You May Not Know About
Understanding these other forms of dementia is essential for early detection, proper treatment, and support for both patients and caregivers.
-
Enzyme Link To Memory Loss In Mice Could Lead To Alzheimer's Breakthrough
A new mice study may have found an association between an enzyme and memory loss in elderly people, an advance that can someday pave the way for the treatment of Alzheimer's disease and dementia.
-
World Alzheimer's Day 2023: Here's How Alzheimer's Symptoms Are Different From Age-Related Forgetfulness
World Alzheimer's Day 2023: Read on as we discuss how Alzheimer's symptoms differ from normal forgetfulness.
-
Brain: These 9 Everyday Practices Will Lower Your Risk Of Alzheimer's Disease
Keep reading as we list everyday habits that can reduce your risk of developing Alzheimer's disease.
-
Groundbreaking New Alzheimer's Drug Slows Progression Of The Disease, Finds Study
The medication had a successful clinical trial and is expected to be approved by the Food and Drug Administration this fall.
-
This AI Tool Makes Personalized Alzheimer's Treatment Plans For Dementia Patients
RestoreU is an AI tool developed by a US-based company to assist doctors in developing care plans for patients with Alzheimer's and other kinds of dementia.
-
What Is Frontotemporal Dementia? All About Bruce Willis' Diagnosis
Frontotemporal dementia is a common cause of dementia, is a group of disorders that occur when nerve cells in the frontal and temporal lobes of the brain are lost.
-
New Study Might Lead to New Therapeutic Approach for Treating Alzheimer’s Disease
Researchers have used a new CRISPR technology that enables them to control these microglia cells. This, according to the team, can lead to a new approach to the treatment of Alzheimer's disease. The team geared up to detect the genes that were responsible for specific states of the microglial activity. With this, they could switch the genes on and ...
